Premium
Everolimus in Heart Transplantation: Does It Finally Have a Home?
Author(s) -
Kobashigawa J. A.,
Zuckermann A. O.
Publication year - 2014
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.12805
Subject(s) - medicine , everolimus , calcineurin , heart transplantation , intravascular ultrasound , transplantation , cardiology , renal function , urology , surgery , intensive care medicine
This editorial approves the use of everolimus to wean calcineurin inhibitors (by 7–11 weeks postoperative) as safe and effective with improved first‐year renal function and reduced intimal thickness by intravascular ultrasound. See article by Andreassen et al on page 1828.